Quality-of-life outcomes of treatments for cutaneous basal cell carcinoma and squamous cell carcinoma

Journal of Investigative Dermatology

Volumn 127, Issue 6, 2007, Pages 1351-1357

  Chren, Mary Margaret ^a,b,c   Sahay, Anju P ^a   Bertenthal, Daniel S ^a   Sen, Saunak ^a,b   Landefeld, C Seth ^a,b,c  

^a SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; BASAL CELL CARCINOMA; CANCER SURGERY; CHEMOSURGERY; CLINICAL PRACTICE; COHORT ANALYSIS; CONTROLLED STUDY; COURSE EVALUATION; EMOTION; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; SCORING SYSTEM; SQUAMOUS CELL CARCINOMA; SURGICAL TECHNIQUE; SYMPTOM; THERAPY EFFECT; TREATMENT OUTCOME; UNIVERSITY HOSPITAL; VALIDATION STUDY;

AGED; AGED, 80 AND OVER; CARCINOMA, BASAL CELL; CARCINOMA, SQUAMOUS CELL; EMOTIONS; FEMALE; FOLLOW-UP STUDIES; HEALTH STATUS INDICATORS; HUMANS; MALE; MIDDLE AGED; MOHS SURGERY; PROSPECTIVE STUDIES; QUALITY OF LIFE; SKIN NEOPLASMS; TREATMENT OUTCOME;

EID: 34248590794     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/sj.jid.5700740     Document Type: Article

References (29)

1. Bath-Hextall F, Bong J, Perkins W, Williams H (2004) Interventions for basal cell carcinoma of the skin: systematic review. BMJ 329:705
2. Charlson ME, Pompei PP, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis 40:373-83
3. Chren MM, Lasek RJ, Sahay AP, Sands LP (2001) Measurement properties of Skindex-16, a brief quality-of-life measure for patients with skin diseases. J Cutaneous Med Surg 5:105-10
4. Chren MM, Sahay AP, Sands LP, Maddock L, Lindquist K, Bertenthal D et al. (2004) Variation in care for nonmelanoma skin cancer in a private practice and a veterans affairs clinic. Med Care 42:1019-26
5. Cook J, Zitelli JA (1998) Mohs micrographic surgery: a cost analysis. J Am Acad Dermatol 39:698-703
6. D'Agostino RB Jr (1998) Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med 17:2265-81
7. Essers BA, Dirksen CD, Nieman FH, Smeets NW, Krekels GA, Prins MH et al. (2006) Cost-effectiveness of mohs micrographic surgery vs surgical excision for basal cell carcinoma of the face. Arch Dermatol 142:187-94
8. Guyatt GH, Feeny DH, Patrick DL (1993) Measuring health-related quality of life. Ann Intern Med 118:622-9
9. Guyatt GH, Osoba D, Wu AW, Wyrwich KW, Norman GR (2002) Methods to explain the clinical significance of health status measures. Mayo Clin Proc 77:371-83
10. Housman TS, Feldman SR, Williford PM, Fleischer AB Jr, Goldman ND, Acostamadiedo JM et al. (2003) Skin cancer is among the most costly of all cancers to treat for the Medicare population. J Am Acad Dermatol 48:425-9
11. Joseph AK, Mark TL, Mueller C (2001) The period prevalence and costs of treating nonmelanoma skin cancers in patients over 65 years of age covered by medicare. Dermatol Surg 27:955-9
12. Juniper EF, Guyatt GH, Willan A, Griffith LE (1994) Determining a minimal important change in a disease-specific Quality of Life Questionnaire. J Clin Epidemiol 47:81-7
13. Katz JN, Chang LC, Sangha O, Fossel AH, Bates DW (1996) Can comorbidity be measured by questionnaire rather than medical record review? Med Care 34:73-84
14. NCCN (2005) Basal and squamous cell skin cancer guidelines. In: National Comprehensive Cancer Network The complete library of NCCN Clinical Practice Guidelines in Oncology. Version 22005 PA: Jenkintown
15. Otley CC (2005) Mohs' micrographic surgery for basal-cell carcinoma of the face. Lancet 365:1226-7; author reply 1227
16. Parsons L (2001) Reducing bias in a propensity score matched-pair sample using greedy matching techniques. In: Proceedings of the Twenty-Sixth Annual SAS Users Group International Conference. Long Beach, CA: SAS Institute Inc
17. Patrick DL, Deyo RA (1989) Generic and disease-specific measures in assessing health status and quality of life. Med Care 27:S217-32
18. Peck BM, Asch DA, Goold SD, Roter DL, Ubel PA, McIntyre LM et al. (2001) Measuring patient expectations: does the instrument affect satisfaction or expectations? Med Care 39:100-8
19. Rowe DE (1995) Comparison of treatment modalities for basal cell carcinoma. Clin Dermatol 13:617-20
20. Rubin AI, Chen EH, Ratner D (2005) Basal-cell carcinoma. N Engl J Med 353:2262-9
21. Rubin DB (1997) Estimating causal effects from large data sets using propensity scores. Ann Intern Med 127:757-63
22. Smeets N (2005) Little evidence available on treatments for basal cell carcinoma of the skin. Cancer Treat Rev 31:143-6
23. Smeets NW, Krekels GA, Ostertag JU, Essers BA, Dirksen CD, Nieman FH et al. (2004a) Surgical excision vs Mohs'micrographic surgery for basal-cell carcinoma of the face: randomised controlled trial. Lancet 364:1766-72
24. Smeets NW, Kuijpers DI, Nelemans P, Ostertag JU, Verhaegh ME, Krekels GA et al. (2004b) Mohs'micrographic surgery for treatment of basal cell carcinoma of the face - results of a retrospective study and review of the literature. Br J Dermatol 151:141-7
25. Sprangers MA, Moinpour CM, Moynihan TJ, Patrick DL, Revicki DA (2002) Assessing meaningful change in quality of life over time: a users' guide for clinicians. Mayo Clin Proc 77:561-71
26. Swanson NA, Grekin RC, Baker SR (1983) Mohs surgery: techniques, indications, and applications in head and neck surgery. Head Neck Surg 6:683-92
27. Thissen MR, Neumann MH, Schouten LJ (1999) A systematic review of treatment modalities for primary basal cell carcinomas. Arch Dermatol 135:1177-83
28. Ware J Jr, Kosinski M, Keller SD (1996) A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care 34:220-33
29. Welch ML, Anderson LL, Grabski WJ (1999) Evaluation and management of nonmelanoma skin cancer. The military perspective. Dermatol Clin 17:19-28, vii